Zobrazeno 1 - 10
of 986
pro vyhledávání: '"RADIOACTIVE IODINE THERAPY"'
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Purpose Papillary thyroid cancer (PTC) is the most common thyroid malignancy, characterized by its slow progression and favorable prognosis. This study re-evaluates the efficacy of radioactive iodine (RAI) therapy versus no RAI in low-risk P
Externí odkaz:
https://doaj.org/article/e3c556f2fa4646e58f1bec5bbb0dbfab
Autor:
Azam Keshavarzi, Fariba Alaei-Shahmiri, Babak Fallahi, Zahra Emami, Mojtaba Malek, Mohammad E. Khamseh
Publikováno v:
BMC Endocrine Disorders, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Radioactive iodine (RAI) therapy is the standard treatment approach after total thyroidectomy in patients with papillary thyroid carcinoma (PTC). We aimed to identify predictive factors of response to the treatment in intermediate
Externí odkaz:
https://doaj.org/article/f55adae55a204d84b4c8ea121f610f57
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
It is well established that patients with the most differentiated thyroid cancers have a good prognosis, whereas when the disease develops into radio-iodine refractory thyroid cancer (RAIR) their prognosis is poor and the 10-year survival rate is low
Externí odkaz:
https://doaj.org/article/6c23b61d01c9425493971f0f87c60f0c
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
IntroductionRadioactive iodine (RAI) has been utilized for nearly 80 years in treating both hyperthyroidism and thyroid cancer, and it continues to play a central role in the management of differentiated thyroid cancer (DTC) today. Recently, the use
Externí odkaz:
https://doaj.org/article/43bf67dbae85461a97174e4051775c78
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
BackgroundRadioactive iodine (RAI) therapy is a widely used treatment for Graves’ Hyperthyroidism (GH). However, various factors can impact the non-remission rate of GH after single RAI therapy. This study aimed to develop an online dynamic nomogra
Externí odkaz:
https://doaj.org/article/d7e6c6bd399440dfa31f1738ecc99bbb
Autor:
Jian-Jing Liu, Zi-Yang Wang, Yuan-Fang Yue, Guo-Tao Yin, Li-Na Tong, Jie Fu, Xiao-Ying Ma, Yan Li, Xue-Yao Liu, Li-Bo Zhang, Qian Su, Zhao Yang, Xiao-Feng Li, Wen-Gui Xu, Dong Dai
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
PurposeTo develop a predictive model using machine learning for levothyroxine (L-T4) dose selection in patients with differentiated thyroid cancer (DTC) after resection and radioactive iodine (RAI) therapy and to prospectively validate the accuracy o
Externí odkaz:
https://doaj.org/article/5b24e41f39b945c0be29ecc749a15c41
Publikováno v:
Biomolecules & Biomedicine (2024)
The effective iodine-131 (I-131) half-life (EHL) plays an important role in the evaluation of radioactive iodine therapy for Graves’ disease (GD) patients. It has been observed that the EHL of GD patients varies after taking lithium carbonate. The
Externí odkaz:
https://doaj.org/article/b316ff71ea2b4c91aafb6ffa39c7445e
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
ObjectivesThe growing incidence of differentiated thyroid cancer (DTC) have been linked to insulin resistance and metabolic syndrome. The imperative need for developing effective diagnostic imaging tools to predict the non-iodine-avid status of lung
Externí odkaz:
https://doaj.org/article/a2b9f97897ff4c68adcedfe7d8726617
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2024)
ObjectiveThis retrospective study aims to evaluate the therapeutic effect of varying dosages of adjuvant radioactive iodine (RAI) therapy on intermediate-risk papillary thyroid carcinoma (PTC) patients.MethodsThis retrospective study involved a total
Externí odkaz:
https://doaj.org/article/c44c2cf1613248be9694cda790d650db
Publikováno v:
BMC Endocrine Disorders, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Liver dysfunction is a common complication of Graves’ disease (GD) that may be caused by excessive thyroid hormone (TH) or anti-thyroid drugs (ATDs). Radioactive iodine (RAI) therapy is one of the first-line treatments for GD, but it is un
Externí odkaz:
https://doaj.org/article/21ec16a1e39649489025c8c5b88e36a2